1. Market Research
  2. > Healthcare Market Trends
  3. > Home Healthcare Market Analysis By Product, By Service And Segment Forecast to 2020

The global market for home healthcare is expected to reach USD 355.3 billion by 2020, growing at an estimated CAGR of 7.8% from 2014 to 2020. Home healthcare products are generally applied to a broad range of equipment and services designed for exclusive use for home or other non-medical establishments by non-professional caregivers, family members, or the patients themselves. Increasing adoption of telehealth and other emerging healthcare technologies are expected to drive market growth over the forecast period. Home healthcare is rapidly getting adopted as a cost effective alternative to healthcare establishment based therapy and therefore, growing geriatric population base and prevalence of chronic conditions requiring long term care is also expected to have a positive impact on growth. Presence of untapped potential in emerging markets such as India, Brazil and China and increasing health awareness are expected to serve this market as future growth opportunities.

Further Key findings from the study suggest:

Home healthcare services dominated the overall market, accounting for over 85% of global revenue in 2013, due to increasing demand for Infusion therapy services and telemetry.

Infusion therapy is expected to be the fastest growing services market, at an estimated CAGR of 11.7% from 2014 to 2020. Increasing initiatives undertaken by healthcare service providers to curb costs associated with specialty drugs and by retail pharmacies to render efficient chronic disease management solutions are some of the drivers of this market.

Home healthcare based diagnostics dominated the product market in terms of share at 41.4% in 2013. Growing prevalence diabetes and cardiovascular diseases and the consequent rise in demand for constant patient monitoring is one of the major factors attributing to its large share.

North America was the largest regional market in 2013, accounting for over 40% of the revenue. Presence of sophisticated healthcare and reimbursement infrastructure, high patient awareness levels and healthcare expenditure are some of the factors accounting for its large share. In addition, increasing R&D initiatives aimed at developing new products suitable for use in home healthcare environments is expected to boost market demand in this region.

Asia Pacific home healthcare market is expected to grow at the fastest CAGR of 9.7% from 2014 to 2020 majorly owing to high unmet medical needs coupled with rapidly improving healthcare infrastructure in emerging markets of India and China. Presence of a large geriatric population base in Japan is also expected to drive regional market growth during the forecast period.

Key industry participants of this market include Almost Family Inc., B. Braun Melsungen AG, Abbott Laboratories, Sunrise Medical Inc., 3M healthcare, Baxter international Inc., Medtronic Inc., Cardinal health Inc., Roche diagnostics corp., Air liquid, Arcadia resources, Inc., Bayer healthcare AG, Amedisys, Inc., Nxstage Medical, Inc., Arkray Inc., Apria healthcare group, Odyssey Healthcare Inc., Medline Industries Inc., Philips healthcare, Medco Health Solutions Inc., Graham-Field health products Inc., Hill-Rom holdings Inc., Gentiva health services Inc., Johnson & Johnson, Linde Healthcare, Lincare holdings Inc. and Kinetic concepts .

For the purpose of this study, Grand View Research has segmented the home healthcare market on the basis of product, services and region:
- Home Healthcare Product Outlook
- Therapeutic equipment
- Home respiratory therapy equipment
- Home insulin delivery devices
- Home IV pumps
- Other therapeutic equipment
- Home dialysis equipment
- Home diagnostic equipment
- Home diabetes care devices
- Home blood pressure monitors
- Home multi-parameter patient monitors
- Home pregnancy and fertility tests
- Other self monitoring equipment
- Apnea and sleep monitors
- Holter monitors
- Heart rate meters
- Mobility assist and other equipment
- Wheelchairs and related devices
- Home medical furniture
- Walking assist devices
- Home Healthcare Service Outlook
- Rehabilitation service providers
- Unskilled home care
- Respiratory therapy services
- Infusion therapy
- Telemetry
- Home Healthcare Regional Outlook
- North America
- Europe
- Asia Pacific
- RoW

Table Of Contents

Home Healthcare Market Analysis By Product, By Service And Segment Forecast to 2020
Table of Contents

Chapter 1. Executive Summary

1.1. Home Healthcare Market - Industry Summary and Critical Success Factors (CSFs)

Chapter 2. Home Healthcare Industry Outlook

2.1. Market Segmentation

2.2. Market Size and Growth Prospects

2.3. Home Healthcare Market Dynamics

2.3.1. Market Driver Analysis

2.3.2. Market Restraint Analysis

2.4. Key Opportunities Prioritized

2.5. Industry Analysis - Porter's

2.6. Home Healthcare - Company Market Share Analysis

2.7. Home Healthcare Market PESTEL Analysis, 2012

Chapter 3. Home Healthcare Product Outlook

3.1. Therapeutic Equipment (TE)

3.1.1. Home Respiratory TE Market Estimates and Forecasts, 2012 - 2020 (USD Million)

3.1.2. Insulin Delivery Market Estimates and Forecasts, 2012 - 2020 (USD Million)

3.1.3. Home IV Pumps Equipment Market Estimates and Forecasts, 2012 - 2020 (USD Million)

3.1.4. Other TE Market Estimates and Forecasts, 2012 - 2020 (USD Million)

3.1.5. Home Dialysis Equipment Market Estimates and Forecasts, 2012 - 2020 (USD Million)

3.2. Diagnostic Equipment

3.2.1. Diagnostics Equipment Market Estimates and Forecasts, 2012 - 2020 (USD Million)

3.2.2. Diabetic Care Unit Market Estimates and Forecasts, 2012 - 2020 (USD Million)

3.2.3. BP monitors Market Estimates and Forecasts, 2012 - 2020 (USD Million)

3.2.4. Multi Parameter Monitors Market Estimates and Forecasts, 2012 - 2020 (USD Million)

3.2.5. Home Pregnancy And Fertility Kits Market Estimates and Forecasts, 2012 - 2020 (USD Million)

3.2.6. Others Self Monitoring Equipment Market Estimates and Forecasts, 2012 - 2020 (USD Million)

3.2.7. Apnea And Sleep Monitors Market Estimates and Forecasts, 2012 - 2020 (USD Million)

3.2.8. Holter Monitors Market Estimates and Forecasts, 2012 - 2020 (USD Million)

3.2.9. Heart Rate Meters Market Estimates and Forecasts, 2012 - 2020 (USD Million)

3.3. Mobility Assist Equipment

3.3.1. Mobility Assist Equipment Market Estimates and Forecasts, 2012 - 2020 (USD Million)

3.3.2. Wheel chair Market Estimates and Forecasts, 2012 - 2020 (USD Million)

3.3.3. Home medical furniture Market Estimates and Forecasts, 2012 - 2020 (USD Million)

3.3.4. Walking assist devices Market Estimates and Forecasts, 2012 - 2020 (USD Million)

Chapter 4. Home Healthcare Service Outlook

4.1. Rehabilitation services Market Estimates and Forecasts, 2012 - 2020 (USD Million)

4.2. Unskilled home care Market Estimates and Forecasts, 2012 - 2020 (USD Million)

4.3. Respiratory therapy services Market Estimates and Forecasts, 2012 - 2020 (USD Million)

4.4. Infusion therapy services Market Estimates and Forecasts, 2012 - 2020 (USD Million)

4.5. Telemetry Market Estimates and Forecasts, 2012 - 2020 (USD Million)

Chapter 5. Home Healthcare Regional Outlook

5.1. North America

5.1.1. Home Healthcare Market Estimates and Forecasts, by Product, 2012 - 2020 (USD Million)

5.1.2. Home Healthcare Market Estimates and Forecasts, by Service, 2012 - 2020 (USD Million)

5.2. Europe

5.2.1. Home Healthcare Market Estimates and Forecasts, by Product, 2012 - 2020 (USD Million)

5.2.2. Home Healthcare Market Estimates and Forecasts, by Service, 2012 - 2020 (USD Million)

5.3. Asia Pacific

5.3.1. Home Healthcare Market Estimates and Forecasts, by Product, 2012 - 2020 (USD Million)

5.3.2. Home Healthcare Market Estimates and Forecasts, by Service, 2012 - 2020 (USD Million)

5.4. RoW

5.4.1. Home Healthcare Market Estimates and Forecasts, by Product, 2012 - 2020 (USD Million)

5.4.2. Home Healthcare Market Estimates and Forecasts, by Service, 2012 - 2020 (USD Million)

Chapter 6 Competitive Landscape

6.1 Almost Family Inc.

6.1.1 Company Overview

6.1.2 Financial Performance

6.1.3 Product Benchmarking

6.1.4 Strategic Initiatives

6.2 B. Braun Melsungen AG

6.2.1 Company Overview

6.2.2 Financial Performance

6.2.3 Product Benchmarking

6.2.4 Strategic Initiatives

6.3 Abbott Laboratories

6.3.1 Company Overview

6.3.2 Financial Performance

6.3.3 Product Benchmarking

6.3.4 Strategic Initiatives

6.4 Sunrise Medical Inc.

6.4.1 Company Overview

6.4.2 Financial Performance

6.4.3 Product Benchmarking

6.4.4 Strategic Initiatives

6.5 3M Healthcare

6.5.1 Company Overview

6.5.2 Financial Performance

6.5.3 Product Benchmarking

6.5.4 Strategic Initiatives

6.6 Baxter International Inc.

6.6.1 Company Overview

6.6.2 Financial Performance

6.6.3 Product Benchmarking

6.6.4 Strategic Initiatives

6.7 Medtronic Inc.

6.7.1 Company Overview

6.7.2 Financial Performance

6.7.3 Product Benchmarking

6.7.4 Strategic Initiatives

6.8 Cardinal Health Inc.

6.8.1 Company Overview

6.8.2 Financial Performance

6.8.3 Product Benchmarking

6.8.4 Strategic Initiatives

6.9 Roche Diagnostics Corp.

6.9.1 Company Overview

6.9.2 Financial Performance

6.9.3 Product Benchmarking

6.9.4 Strategic Initiatives

6.10 Air Liquide

6.10.1 Company Overview

6.10.2 Financial Performance

6.10.3 Product Benchmarking

6.10.4 Strategic Initiatives

6.11 Arcadia Resources, Inc.

6.11.1 Company Overview

6.11.2 Financial Performance

6.11.3 Product Benchmarking

6.11.4 Strategic Initiatives

6.12 Bayer Healthcare AG

6.12.1 Company Overview

6.12.2 Financial Performance

6.12.3 Product Benchmarking

6.12.4 Strategic Initiatives

6.13 Amedisys, Inc.

6.13.1 Company Overview

6.13.2 Financial Performance

6.13.3 Product Benchmarking

6.13.4 Strategic Initiatives

6.14 Nxstage Medical, Inc

6.14.1 Company Overview

6.14.2 Financial Performance

6.14.3 Product Benchmarking

6.14.4 Strategic Initiatives

6.15 Arkray Inc.

6.15.1 Company Overview

6.15.2 Financial Performance

6.15.3 Product Benchmarking

6.15.4 Strategic Initiatives

6.16 Apria Healthcare Group

6.16.1 Company Overview

6.16.2 Financial Performance

6.16.3 Product Benchmarking

6.16.4 Strategic Initiatives

6.17 Odyssey Healthcare Inc.

6.17.1 Company Overview

6.17.2 Financial Performance

6.17.3 Product Benchmarking

6.17.4 Strategic Initiatives

6.18 Becton, Dickinson And Company

6.18.1 Company Overview

6.18.2 Financial Performance

6.18.3 Product Benchmarking

6.18.4 Strategic Initiatives

6.19 Critical Homecare

6.19.1 Company Overview

6.19.2 Financial Performance

6.19.3 Product Benchmarking

6.19.4 Strategic Initiatives

6.20 National Healthcare Corp.

6.20.1 Company Overview

6.20.2 Financial Performance

6.20.3 Product Benchmarking

6.20.4 Strategic Initiatives

6.21 Omron Healthcare, Inc.

6.21.1 Company Overview

6.21.2 Financial Performance

6.21.3 Product Benchmarking

6.21.4 Strategic Initiatives

6.22 Drive Medical Design and Manufacturing

6.22.1 Company Overview

6.22.2 Financial Performance

6.22.3 Product Benchmarking

6.22.4 Strategic Initiatives

6.23 Chubb Community Care

6.23.1 Company Overview

6.23.2 Financial Performance

6.23.3 Product Benchmarking

6.23.4 Strategic Initiatives

6.24 Gambro AB

6.24.1 Company Overview

6.24.2 Financial Performance

6.24.3 Product Benchmarking

6.12.4 Strategic Initiatives

6.25 GE Healthcare

6.25.1 Company Overview

6.25.2 Financial Performance

6.25.3 Product Benchmarking

6.25.4 Strategic Initiatives

6.26 Medline Industries Inc.

6.26.1 Company Overview

6.26.2 Financial Performance

6.26.3 Product Benchmarking

6.26.4 Strategic Initiatives

6.27 Philips Healthcare

6.27.1 Company Overview

6.27.2 Financial Performance

6.27.3 Product Benchmarking

6.27.4 Strategic Initiatives

6.28 Medco Health Solutions Inc.

6.28.1 Company Overview

6.28.2 Financial Performance

6.28.3 Product Benchmarking

6.28.4 Strategic Initiatives

6.29 Graham-Field Health Products Inc.

6.29.1 Company Overview

6.29.2 Financial Performance

6.29.3 Product Benchmarking

6.29.4 Strategic Initiatives

6.30 Hill-Rom Holdings Inc.

6.30.1 Company Overview

6.30.2 Financial Performance

6.30.3 Product Benchmarking

6.30.4 Strategic Initiatives

6.31 Gentiva Health Services Inc

6.31.1 Company Overview

6.31.2 Financial Performance

6.31.3 Product Benchmarking

6.31.4 Strategic Initiatives

6.32 Johnson and Johnson

6.32.1 Company Overview

6.32.2 Financial Performance

6.32.3 Product Benchmarking

6.32.4 Strategic Initiatives

6.33 Linde Healthcare

6.33.1 Company Overview

6.33.2 Financial Performance

6.33.3 Product Benchmarking

6.33.4 Strategic Initiatives

6.34 Lincare Holdings, Inc.

6.34.1 Company Overview

6.34.2 Financial Performance

6.34.3 Product Benchmarking

6.34.4 Strategic Initiatives

6.35 Kinetic Concepts

6.35.1 Company Overview

6.35.2 Financial Performance

6.35.3 Product Benchmarking

6.35.4 Strategic Initiatives

6.36 Carefusion

6.36.1 Company Overview

6.36.2 Financial Performance

6.36.3 Product Benchmarking

6.36.4 Strategic Initiatives

6.37 Covidien

6.37.1 Company Overview

6.37.2 Financial Performance

6.37.3 Product Benchmarking

6.37.4 Strategic Initiatives

6.38 Vygon

6.38.1 Company Overview

6.38.2 Financial Performance

6.38.3 Product Benchmarking

6.38.4 Strategic Initiatives

6.39 Teleflex

6.39.1 Company Overview

6.39.2 Financial Performance

6.39.3 Product Benchmarking

6.39.4 Strategic Initiatives

6.40 Terumo

6.40.1 Company Overview

6.40.2 Financial Performance

6.40.3 Product Benchmarking

6.40.4 Strategic Initiatives

6.41 Moog Inc.

6.41.1 Company Overview

6.41.2 Financial Performance

6.41.3 Product Benchmarking

6.41.4 Strategic Initiatives

6.42 Intersurgical

6.42.1 Company Overview

6.42.2 Financial Performance

6.42.3 Product Benchmarking

6.42.4 Strategic Initiatives

6.43 Fresenius Kabi

6.43.1 Company Overview

6.43.2 Financial Performance

6.43.3 Product Benchmarking

6.43.4 Strategic Initiatives

Chapter 7. Methodology and Scope

7.1. Research Methodology

7.2. Research Scope and Assumption

7.3. List of Data Sources


List of Tables

1. Home healthcare- Industry summary and Critical Success Factors (CSFs)
2. Global home healthcare revenue, 2012 - 2020
3. Global home healthcare market revenue by region, (USD million), 2012 - 2020
4. Global home healthcare market revenue by equipment, (USD million), 2012 - 2020
5. Global therapeutic equipment market, 2012 to 2020 (USD million)
6. Global home respiratory therapy equipment market, 2012 to 2020 (USD million)
7. Global insulin delivery equipment market, 2012 to 2020 (USD million)
8. Global home IV (intravenous) pumps market, 2012 to 2020 (USD million)
9. Global others therapeutic equipment market, 2012 to 2020 (USD million)
10. Global home dialysis equipment market, 2012 to 2020 (USD million)
11. Global diagnostic equipment market, 2012 to 2020 (USD million)
12. Global diabetic care unit market, 2012 to 2020 (USD million)
13. Global BP monitors market, 2012 to 2020 (USD million)
14. Global multi parameter diagnostic monitors market, 2012 to 2020 (USD million)
15. Global home pregnancy and fertility kits market, 2012 to 2020 (USD million)
16. Global others self monitoring equipment market, 2012 to 2020 (USD million)
17. Global Apnea and sleep monitors market, 2012 to 2020 (USD million)
18. Global Holter monitors market, 2012 to 2020 (USD million)
19. Global heart rate meters(include pacemakers) market, 2012 to 2020 (USD million)
20. Global mobility assist equipment market, 2012 to 2020 (USD million)
21. Global wheelchairs market, 2012 to 2020 (USD million)
22. Global home medical furniture market, 2012 to 2020 (USD million)
23. Global walking assist devices market, 2012 to 2020 (USD million)
24. Global home healthcare market revenue by service, (USD million), 2012 - 2020
25. Global rehabilitation service providers market, 2012 to 2020 (USD million)
26. Global Unskilled home care market, 2012 to 2020 (USD million)
27. Global respiratory therapy services market, 2012 to 2020 (USD million)
28. Global infusion therapy market, 2012 to 2020 (USD million)
29. Global telemetry/telehealth market, 2012 to 2020 (USD million)
30. Global home healthcare market, by region, 2012 to 2020 (USD million)
31. North America home healthcare demand, by equipment, (USD million), 2012 - 2020
32. North America home healthcare demand, by service, (USD million), 2012 - 2020
33. Europe home healthcare demand, by equipment, (USD million), 2012 - 2020
34. Europe home healthcare demand, by service, (USD million), 2012 - 2020
35. Asia Pacific home healthcare demand, by equipment, (USD million), 2012 - 2020
36. Asia Pacific home healthcare demand, by service, (USD million), 2012 - 2020
37. RoW home healthcare demand, by equipment, (USD million), 2012 - 2020
38. RoW home healthcare demand, by service, (USD million), 2012 - 2020
39. Global home healthcare Market - Competitive Landscape


List of Figures

1. Home Healthcare Market Segmentation
2. Global Home Healthcare Market Revenue, 2012 - 2020
3. Home healthcare Market Dynamics
4. Home Healthcare Company Market Share Analysis, 2012
5. Key Opportunities Prioritized
6. Industry Analysis - Porter's
7. Home healthcare PESTEL Analysis, 2012
8. Global home healthcare market, by equipment, (USD million), 2012 - 2020
9. Global therapeutic equipment market, by region, (USD million), 2012 to 2020
10. Global home IV equipment market, by region, (USD million), 2012 to 2020
11. Global home respiratory therapy equipment market, by region(USD million), 2012 to 2020
12. Global home insulin delivery devices market, by region, (USD million), 2012 to 2020
13. Global Home IV (intravenous) pumps market, by region, (USD million), 2012 to 2020
14. Global other therapeutic equipment market, by region, (USD million), 2012 to 2020
15. Global home self diagnostic or monitoring equipment market, by region, 2012 to 2020
16. Global Home dialysis equipment market, by region, (USD million), 2012 to 2020
17. Global diagnostics market, by region, (USD million), 2012 to 2020
18. Global Diabetic care unit market, by region, (USD million), 2012 to 2020
19. Global home blood pressure monitors market, by region, (USD million), 2012 to 2020
20. Global multi parameter diagnostic monitors market, by region, (USD million), 2012 to 2020
21. Global home pregnancy and fertility kits market, by region, (USD million), 2012 to 2020
22. Global Others self monitoring equipment market, by region, (USD million), 2012 to 2020
23. Global home - apnea and sleep monitors market, by region, (USD million), 2012 to 2020
24. Global home holter monitors market, by region, (USD million), 2012 to 2020
25. Global heart rate meters market, by region, (USD million), 2012 to 2020
26. Global mobility assist market, by region, (USD million), 2012 to 2020
27. Global wheelchairs devices market, by region, (USD million), 2012 to 2020
28. Global home medical furniture market, by region, (USD million), 2012 to 2020
29. Global walking assist devices market, by region, (USD million), 2012 to 2020
30. Global home healthcare market, by service, (USD million), 2012 - 2020
31. Global rehabilitation service providers market, by region, (USD million), 2012 to 2020
32. Global Unskilled home care market, by region, (USD million), 2012 to 2020
33. Global respiratory therapy services market, by region, (USD million), 2012 to 2020
34. Global infusion therapy market, by region, (USD million), 2012 to 2020
35. Global telemetry/telehealth market, by region, (USD million), 2012 to 2020
36. Home healthcare market - company market share analysis, 2013 (%)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

  • $ 59500
  • Industry report
  • January 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.